Webinar video | Life Sciences Session #3: ‘Trop is te veel’: what not to do in case of pricing of medicines?

Webinar video | Life Sciences Session #3: ‘Trop is te veel’: what not to do in case of pricing of medicines?
March 23, 2021

The COVID-19 pandemic challenges companies and firms worldwide, and requires us all to adopt new proactive approaches. While COVID-19 prevents us from being together, our Life Sciences team takes the initiative to give you short, digestible and regular online Life Sciences Sessions. 

 Are you trying to see the wood for the trees when setting prices and arranging reimbursement for you medicines in Belgium? Is “the sky the limit” for your medicines’ prices? Or are you also wondering what all the fuzz is about the Commission’s decision towards Aspen?

  • Kirian Claeyé will guide you through the regulatory maze of pricing and reimbursement of medicines in Belgium.
  • Beatrijs Gielen and Nina Methens will clarify the European Courts’ approach towards excessive pricing under competition law, in particular in the pharma sector, and will discuss the long-awaited European Commission settlement decision in the Aspen case.

Contact

  • Kirian Claeyé

    Counsel

  • Beatrijs Gielen

    Counsel

  • Nina Methens

    Associate

Recommended articles

May 05, 2023

EU harmonizes THC limits in hemp seed (food) as from 1 January 2023 – Update Belgium

The EU regulator has harmonized the maximum levels for tetrahydrocannabinol (THC) in hemp seeds throughout the Union within the food contaminants framework.

Read on
April 24, 2023

European Parliament passes sweeping due diligence rules on deforestation-free supply chains for products such as cocoa, coffee and soy

An EU Regulation on the making available on the Union market as well as export from the Union of certain commodities and products associated with deforestation and forest degradation (“Deforestation Regulation”) was agreed upon by the EU legislators in December 2022. The European Parliament has now green-lighted the Provisional Agreement at this month’s plenary session.

Read on
March 14, 2023

WEBINAR VIDEO | The N°1, healthy, rich in learning webinar about claims

During this session, Mathieu Maniet, François Lambert and Karel Martens discuss the rules for No. 1 claims, cosmetic claims and health and nutrition claims, and give you an overview of the most important issues as well as practical guidelines.

Read on